GC Cell Corporation (KOSDAQ:144510)
South Korea · Delayed Price · Currency is KRW 21,650
+200 (0.93%)
Jul 18, 2025, 3:30 PM KST
GC Cell Company Description
GC Cell Corporation develops cell therapy products.
It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC.
GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy.
The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021.
GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.
GC Cell Corporation
| Country | South Korea |
| Founded | 2011 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 752 |
| CEO | Jong-Eun Park |
Contact Details
Address: 107, Ihyeon-ro Yongin-si, 16924 South Korea | |
| Phone | 82 3 1260 9600 |
| Website | gccell.com |
Stock Details
| Ticker Symbol | 144510 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7144510005 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jong-Eun Park | Chief Executive Officer |